HTR6 and obesity due to melanocortin 4 receptor deficiency: The interesting pharmacological properties together with a promising “drugability” designate this group of chemical molecules as a good starting point for further consideration in order to explore molecular mechanisms of the 5-HT6R–ligand interaction, and even to search of new drug candidates for the treatment of depression and obesity.